Search

Equity Firm J.P. Morgan Chase Subsidiary One Equity Partners Buys Peroxychem

| Editor: Dominik Stephan

Holding company J.P. Morgan buys speciality chemicals firm: One Equity Partners, a global private investment arm of J.P. Morgan Chase & Co has taken over Peroxychem, the former FMC division FMC Global Peroxygens.

Related Company

FMC Corporation Completes Sale of Peroxygens Business to One Equity Partners
FMC Corporation Completes Sale of Peroxygens Business to One Equity Partners
(Picture: Ernhofer/PROCESS)

Philadelphia, Pennsylvania/USA – One Equity Partners communicated plans to develop Peroxychem to become “a global leader in the manufacturing of hydrogen peroxide, persulfates, peracetic acid and environmental remediation technologies”, the company states. PeroxyChem expects no changes to daily operations as a result of the sale.

“Peroxychem’s strategy is to be fully focused on the production and innovation of high quality peroxygen products and related technologies for a diverse set of industrial and specialty markets,” said Bruce Lerner, Peroxychem's President and CEO. “With a portfolio of high quality products, superb technical expertise, as well as operational excellence and a talented team of employees around the world it is a very exciting way to launch a new company.”

Now Peroxychem becomes one of One Equity Partners’chemical businesses among Columbian Chemicals, Süd Chemie, OCI, Chemlogics, Sonneborn and LBC Tank Terminals. One Equity Partners manages capital and commitments of approximately US $14 billion.

(ID:42560449)